ALL ABOUT BLEEDING

Serial Number 88210004
606

Registration Progress

Application Filed
Nov 29, 2018
Under Examination
Dec 17, 2019
Approved for Publication
Oct 22, 2019
Published for Opposition
Oct 22, 2019
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: ALL ABOUT BLEEDING
Previous Owner: CSL Behring L.L.C.
Classes: 016, 035, 041, 042, 044

Trademark Image

ALL ABOUT BLEEDING

Basic Information

Serial Number
88210004
Filing Date
November 29, 2018
Published for Opposition
October 22, 2019
Abandonment Date
January 23, 2023
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 23, 2023
Classes
016 035 041 042
+1 more

Rights Holder

CSL Behring L.L.C.

16
Address
1020 First Avenue
King of Prussia, PA 19406

Ownership History

CSL Behring L.L.C.

Original Applicant
16
King of Prussia, PA

CSL Behring L.L.C.

Owner at Publication
16
King of Prussia, PA

Legal Representation

Attorney
Scott D. Woldow

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

38 events
Date Code Type Description Documents
Jan 23, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jan 23, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
May 21, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 20, 2022 EX5G S SOU EXTENSION 5 GRANTED Loading...
May 17, 2022 EXT5 S SOU EXTENSION 5 FILED Loading...
May 20, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 17, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 20, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 18, 2021 EX4G S SOU EXTENSION 4 GRANTED Loading...
Nov 18, 2021 EXT4 S SOU EXTENSION 4 FILED Loading...
Nov 18, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 19, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 17, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 17, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
May 17, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 19, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 17, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 17, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Nov 17, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 19, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 15, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 15, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
May 15, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 17, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 22, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 22, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 2, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 13, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 12, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 12, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 9, 2019 ALIE A ASSIGNED TO LIE Loading...
Sep 3, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 4, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 4, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 4, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 1, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 17, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 3, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 016
Printed materials, namely, journals, newsletters, articles and case studies featuring blood related diseases, biopharmaceuticals and biotherapies; Printed publications, namely, brochures, booklets, newsletters, articles, case studies, and teaching materials in the field of blood related diseases; printed educational materials in the field of blood related diseases
Class 035
Promoting public awareness of Von Willebrand disease and blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; promoting public awareness of Von Willebrand disease and blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals by means of public advocacy and patient and caregiver public advocacy; public policy research services concerning policy initiatives for Von Willebrand disease and blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; Promoting the donation of blood, volunteer services, and financial resources in the field of blood donations by means of arranging and conducting incentive reward programs
Class 041
Healthcare education services, namely, providing educational and awareness educational training programs for patients, caregivers and/or healthcare professionals concerning Von Willebrand disease and blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; organizing, planning and conducting educational conventions and educational meetings related to Von Willebrand disease and blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals
Class 042
Medical and scientific research in the field of health, wellness, and blood conditions
Class 044
Healthcare and healthcare information services, namely, providing healthcare information concerning Von Willebrand disease and blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; Providing a website featuring information in the field of health, blood, bleeding conditions, and corresponding treatments; Healthcare and healthcare information services, namely, providing healthcare information concerning hemophilia, platelet dysfunction, perioperative bleeding, rare bleeding disorders, fibrinogen deficiency, anticoagulant reversal, and other blood related diseases, treatment and impacts on patients, patient families, caregivers and/or healthcare professionals; Healthcare and healthcare information services, namely, providing healthcare information concerning patient lifestyle and wellness for patients, caregivers, parents, teachers, coaches and friends impacted by bleeding conditions; Providing a website featuring healthcare information in the field of the diagnosis and treatment of blood conditions; Providing links to the web sites of others featuring information about the diagnosis and treatment of blood conditions and treatments

Classification

International Classes
016 035 041 042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BLEEDING"